Human erythroid progenitor cells express Rhesus antigens

Area of Science:

• Hematology
• Immunology
• Stem Cell Biology

Background:

• Rhesus (Rh) antigens are crucial for red blood cell identification.
• Understanding Rh antigen expression on hematopoietic progenitor cells (HPCs) is vital for stem cell research and transplantation.
• Current methods for analyzing Rh antigens on HPCs have limitations.

Purpose of the Study:

• To investigate the expression of Rhesus antigens on various hematopoietic progenitor cells.
• To determine if Rhesus antigens can be used to enrich specific progenitor cell populations.
• To differentiate between mature and immature erythroid progenitor cells based on Rh antigen density.

Main Methods:

• Monoclonal antibodies targeting Rhesus antigens were employed.
• Fluorescence-activated cell sorting (FACS) was utilized due to antibody limitations in complement-dependent cytotoxicity assays.
• Cell sorting was performed using the monoclonal anti-Rh 29 antibody B10.

Main Results:

• A significant enrichment of mature erythroid progenitor cells (CFU-E) was achieved, with up to 68% positive for Rh antigens.
• Immature erythroid progenitor cells (BFU-E) and granulocyte-macrophage progenitor cells (CFU-GM) showed low expression (2% and 3%, respectively).
• The study demonstrated up to a 15-fold enrichment of CFU-E, with some fractions containing over 7% CFU-E.

Conclusions:

• Monoclonal antibodies against Rhesus antigens are effective tools for enriching erythroid-committed stem cells.
• FACS analysis using Rh antibodies can successfully separate mature erythroid progenitor cells from immature ones.
• Rhesus antigens exhibit lower density on CFU-E compared to HLA-DR determinants.